Detalhe da pesquisa
1.
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.
Mol Cell Proteomics
; 13(7): 1814-27, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24742827
2.
HER2-low breast cancer shows a lower immune response compared to HER2-negative cases.
Sci Rep
; 12(1): 12974, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902644
3.
Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
Breast Cancer Res Treat
; 127(1): 33-41, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20379845
4.
Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.
Mol Cell Proteomics
; 8(6): 1278-94, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19329653
5.
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Sci Rep
; 6: 32027, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27558661
6.
Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.
J Clin Invest
; 125(4): 1648-64, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25774502
7.
CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.
Cancer Lett
; 319(1): 49-55, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22202642